CROSSJECT (EPA:ALCJ) | Finanzwire

Basculer en Français

11260	Companies
250136	Keywords
178603	Articles
136030	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 06/04/2025 at 20:21, 1 year 4 months ago

Launch of a capital increase with preferential subscription rights for nearly 5 million euros
CROSSJECT announces capital increase with preferential subscription rights totaling nearly 5 million euros. Existing shareholders and Vatel Capital commit to subscribe 76.4% of the amount. Subscription price set at 1.40 euros. Subscription period from June 12 to June 20, 2025

Capital Increase Subscription Period Preferential Subscription Rights Crossject Vatel Capital
BRIEF

published on 06/03/2025 at 07:35, 1 year 5 months ago

Maxim Group Recommends CROSSJECT with €4.00 Target Price

Buy Recommendation Crossject ZEPIZURE® Needle-free Auto-injector Maxim Group
PRESS RELEASE

published on 06/03/2025 at 07:30, 1 year 5 months ago

Maxim Group initiates the coverage of the CROSSJECT share with a BUY recommendation and a target price of €4.00
Maxim Group initiates coverage of CROSSJECT with BUY recommendation and €4.00 target price. CROSSJECT, a specialty pharma company, looks forward to positive developments with FDA and pipeline

FDA Buy Recommendation Specialty Pharma Crossject Maxim Group
BRIEF

published on 05/27/2025 at 07:35, 1 year 5 months ago

CROSSJECT optimizes its production with the ZENEO® Nest

CDMO Funding Production Crossject ZENEO® Nest
BRIEF

published on 05/20/2025 at 07:35, 1 year 5 months ago

CROSSJECT Plans €5 Million Capital Increase to Boost EUA Approval Activities

Capital Increase Crossject ZEPIZURE® Gemmes Venture EUA Approval
PRESS RELEASE

published on 05/20/2025 at 07:30, 1 year 5 months ago

CROSSJECT prepares for the launch of a capital increase with preferential subscription rights of around 5 million euros in preparation for commercial and production activities linked to EUA approval
CROSSJECT plans 5 million euros capital increase, may increase to 5.8 million euros, Gemmes Venture to guarantee 75% of initial amount, Heights Capital Management supports offer

Capital Increase Crossject Gemmes Venture Heights Capital Management EUA Approval
BRIEF

published on 05/07/2025 at 07:35, 1 year 5 months ago

CROSSJECT: Progress in the EUA authorization application for ZEPIZURE®

FDA USA ZEPIZURE® BARDA CHEMPACK
BRIEF

published on 03/27/2025 at 07:35, 1 year 7 months ago

CROSSJECT Publishes 2024 Financial Results

Financial Results Cash Position Partnerships FDA Filing ZEPIZURE®
PRESS RELEASE

published on 03/27/2025 at 07:30, 1 year 7 months ago

CROSSJECT reports financial results for 2024
CROSSJECT reports financial results for 2024 and progress in clinical and regulatory activities, recruitment of COO, and increased cash position. Key achievements and future plans outlined

Financial Results Cash Position Clinical Activities Crossject Regulatory Development
BRIEF

published on 03/25/2025 at 07:35, 1 year 7 months ago

Strategic partnership between CROSSJECT and ETON PHARMACEUTICALS

Eton Pharmaceuticals Crossject ZENEO® Hydrocortisone Adrenal Insufficiency

Accesswire

Published on 11/03/2026 at 08:00, 11 minutes ago

Caledonia Mining Corporation Plc Notice of Q3 2026 Results and Investor Presentation
Published on 11/03/2026 at 05:45, 2 hours 26 minutes ago

Date of Board Meeting
Published on 11/02/2026 at 23:15, 8 hours 56 minutes ago

ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 9 hours 41 minutes ago

Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 15 hours 11 minutes ago

PPX Mining Initiates Operating Permit Process for Igor Processing Plant

View all ACCESSWIRE

EQS Group

Published on 11/03/2026 at 08:05, 6 minutes ago

Freedom24 plans Geneva office for Q1 2027, deepening ties with Swiss finance and research
Published on 11/03/2026 at 08:00, 11 minutes ago

2CRSi SA: Binding order of over €60 million1: 2CRSi to deliver 83 NVIDIA HGX B300 AI servers to Exaion by the end of 2026
Published on 11/03/2026 at 08:00, 11 minutes ago

Cairn Homes Plc: Transaction in Own Shares
Published on 11/03/2026 at 08:00, 11 minutes ago

V-ZUG expands its international presence in Scandinavia
Published on 11/03/2026 at 07:55, 16 minutes ago

Schaeffler announces further performance improvement program

Les Echos

Published on 11/03/2026 at 07:00, 1 hour 11 minutes ago

bioMérieux – Third-Quarter 2026 Business Review
Published on 11/02/2026 at 21:08, 11 hours 3 minutes ago

GROUPE SFPI LIQUIDIDY CONTRAT H1 2026
Published on 11/02/2026 at 18:30, 13 hours 41 minutes ago

Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 13 hours 54 minutes ago

Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 14 hours 11 minutes ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE